|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.47 USD | +0.76% |
|
-1.50% | -18.90% |
USANA Health Sciences, Inc. reported earnings results for the full year ended December 30, 2023. For the full year, the company reported sales was USD 921.01 million compared to USD 998.6 million a year ago. Net income was USD 63.79 million compared to USD 69.35 million a year ago.
Diluted earnings per share from continuing operations was USD 3.3 compared to USD 3.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.90% | 836M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| +0.32% | 711M |
USANA HEALTH SCIENCES, INC. 
